Results 31 to 40 of about 335 (107)
Ancient species offers contemporary therapeutics: an update on shark V<sub>NAR</sub> single domain antibody sequences, phage libraries and potential clinical applications. [PDF]
ABSTRACTThe antigen binding variable domain (VNAR) of the shark immunoglobulin new antigen receptor (IgNAR) evolved approximately 500 million years ago and it is one of the smallest antibody fragments in the animal kingdom with sizes of 12–15 kDa.
English H, Hong J, Ho M.
europepmc +4 more sources
Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications
Shark is a cartilaginous fish that produces new antigen receptor (IgNAR) antibodies. This antibody is identified with a similar human heavy chain but dissimilar sequences.
Salma Nassor Juma +6 more
doaj +1 more source
Tumor necrosis factor α (TNFα), an important clinical testing factor and drug target, can trigger serious autoimmune diseases and inflammation. Thus, the TNFα antibodies have great potential application in diagnostics and therapy fields.
Linfei Zhao +5 more
doaj +1 more source
Marine-derived microbes and molecules for drug discovery
Increasing attention has been paid to marine-derived biomolecules as sources of therapeutics for autoimmune diseases. Nagasaki Prefecture has many islands and is surrounded by seas, straits, gulfs, bays, and coves, giving it the second longest coastline ...
Yoshimasa Tanaka +8 more
doaj +1 more source
Shark-derived single-domain antibodies for the detection of decapod iridescent virus 1
Decapod iridescent virus 1 (DIV1) has emerged as a novel threat to shrimp farming. The development of a rapid, convenient, and accurate method for diagnosing DIV1 is urgently needed, serving as a key factor in the reduction of the risk of viral outbreaks.
Jinlin Chen +6 more
doaj +1 more source
Elasmobranchs are crucial for comparative studies of evolution, as they belong to the most ancient vertebrate lineages that survived numerous extinction events and persist until today.
Jianqing Wen +14 more
doaj +1 more source
Shark antibodies (Variable New Antigen Receptors, VNARs) are the smallest naturally occurring antibody fragments. Here, the authors screen a VNAR phage display library against the SARS-CoV2 receptor binding domain (RBD) and identify VNARs that neutralize
Obinna C. Ubah +20 more
doaj +1 more source
Brain delivery of biologics using a cross‐species reactive transferrin receptor 1 VNAR shuttle
Abstract Transferrin receptor 1 (TfR1) mediated transcytosis is an attractive strategy to enhance brain uptake of protein drugs, but translation remains a challenge. Here, a single domain shark antibody VNAR fragment (TXB2) with similar affinity to murine and human TfR1 was used to shuttle protein cargo into the brain. TXB2 was fused to a human IgG1 Fc
Dag Sehlin +6 more
wiley +1 more source
Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein
The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is the major target for antibody therapeutics. Shark-derived variable domains of new antigen receptors (VNARs) are the smallest antibody fragments with flexible paratopes that can recognize protein motifs inaccessible to classical antibodies. This study reported four VNARs binders (JM-2,
Yu-Lei Chen +9 more
openaire +2 more sources
Human TNF cytokine neutralization with a vNAR fromHeterodontus franciscishark: A potential therapeutic use [PDF]
The therapeutic use of single domain antibodies (sdAbs) is a promising new approach because these small antibodies maintain antigen recognition and neutralization capacity, have thermal and chemical stability and have good solubility. In this study, using phage display technology, we isolated a variable domain of a IgNAR (vNAR) from a Heterodontus ...
Tanya, Camacho-Villegas +4 more
openaire +2 more sources

